Kisspeptin-10 research explained

Kisspeptin-10 Research: Structure and Laboratory Studies

Kisspeptin-10 Research: Structure and Laboratory Studies

Research only. All AVM Labs USA products are sold strictly for laboratory research. Nothing on this page is medical advice, and nothing here describes use in humans or animals.

Kisspeptin-10 is one of the shortest named fragments in the kisspeptin literature: ten amino acids, and nothing else. This guide explains it the way the laboratory literature does: its molecular structure, how it is synthesized and characterized, and how to read the studies that mention it.

What Kisspeptin-10 is, in laboratory terms

Kisspeptin-10, also written KP-10, is the C-terminal decapeptide fragment of the kisspeptin precursor encoded by the KISS1 gene. It corresponds to residues 112–121 of the human KISS1 product, and to residues 45–54 of metastin, which is why it is also catalogued as metastin (45–54). It is described in the literature as the shortest kisspeptin fragment that retains activity at its named receptor, KISS1R, formerly called GPR54 — which is how research papers identify it.

The name “kisspeptin” covers a family, not a single molecule. KP-10 is the ten-residue member of that family; Kisspeptin-54 (metastin) is a longer peptide that ends with the same ten residues. A paper that says only “kisspeptin” has not identified which member was studied.

Molecular structure

The reported molecular identity of human Kisspeptin-10 is:

  • A ten-amino-acid chain — Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe, written YNWNSFGLRF in one-letter code, with a free N-terminus and a C-terminal amide (-NH2).
  • A molecular formula of C63H83N17O14, with a molecular weight of approximately 1302.4 g/mol and a monoisotopic mass of 1301.63 Da.
  • CAS number 374675-21-5, with PubChem CID 25240297.
  • A C-terminal amide, not a free acid — the final phenylalanine ends in -NH2. A free-acid form would read about one dalton heavier, so the terminus is part of the identity a COA verifies.

At approximately 1302.4 Da, Kisspeptin-10 is a small decapeptide, and that mass is the first identity check on a COA.

These are the structural facts a Certificate of Analysis verifies: the sequence, the ten residues, the C-terminal amide, and the molecular weight.

Kisspeptin-10 is not Kisspeptin-54, and it is not the rodent form

Three names in this family are often confused, and the laboratory tells them apart by structure alone:

  • Kisspeptin-10 (human) is a decapeptide: YNWNSFGLRF-NH2, ten residues, approximately 1302.4 Da, CAS 374675-21-5.
  • Kisspeptin-54 (metastin) is a 54-residue peptide that ends with the same ten residues. It is a different molecule, with a different mass, and a sample labelled KP-10 that reads near the metastin mass is not KP-10.
  • The rodent form of KP-10 ends in tyrosine, not phenylalanine: YNWNSFGLRY-NH2, formula C63H83N17O15, approximately 1318.4 Da, CAS 478507-53-8. One residue at the end, sixteen daltons apart — which is why the sequence on the COA, not the short name alone, settles which form a lot contains.

Different chain lengths, different last residues, different masses — which is why the molecular weight is the first identity check on a COA, not a detail.

How research peptides like Kisspeptin-10 are made: solid-phase synthesis

Like most research peptides, Kisspeptin-10 is produced by solid-phase peptide synthesis (SPPS):

  1. The first amino acid is anchored to a solid resin support.
  2. Amino acids are added one at a time, in the planned sequence, with the growing chain held on the resin.
  3. Protecting groups shield the parts of each amino acid that should not react yet, and are removed at the right step.
  4. The finished chain is cleaved from the resin, amidated at the C-terminus as specified, and purified.

The laboratory controls exactly the same variables as for a longer chain: which amino acids, in which order, and with which stereochemistry. All ten residues are the L-form, and that is part of the identity a COA verifies. Our post on peptide synthesis explains this method in detail.

How Kisspeptin-10 is characterized: identity and purity

A research peptide is not defined by its name alone. In the laboratory it is defined by analytical data, typically:

  • Mass spectrometry (MS): confirms the molecular weight matches the intended sequence. For human KP-10 the observed mass must read approximately 1302.4 Da — not the 1318.4 Da of the rodent form, and not the mass of the 54-residue peptide.
  • High-performance liquid chromatography (HPLC): measures purity and reveals impurities, including deletion sequences or incomplete coupling products from synthesis.
  • Certificate of Analysis (COA): the laboratory document that reports those results for a specific batch.

When comparing research materials, the COA is the document that matters: same compound, different batch, different data. Our guide on how to read a peptide COA explains what each field on that document means.

How Kisspeptin-10 is studied in the literature

Laboratory research on Kisspeptin-10 takes several forms:

  • In vitro receptor assays: measurements of binding and activation at KISS1R (GPR54) in cell-based systems, where conditions are controlled and variables are isolated. KP-10 is the standard short reference ligand in these assays.
  • Structural and analytical studies: stability, solubility and degradation — how the peptide behaves in solution, at different temperatures, and over time.
  • Comparative studies: KP-10 measured alongside longer kisspeptin fragments, so that the ten-residue form can be distinguished from the 54-residue form by sequence and mass.

The record is a laboratory record throughout: cell-based assays and analytical work, with the receptor named as the identifier of the fragment. Most of the work uses the human sequence above; a paper that uses the rodent sequence says so, and the two must not be mixed.

Stability and handling in the laboratory

Peptides are sensitive molecules, and laboratory handling reflects that. The topics researchers document include storage temperature, protection from light and moisture, freeze–thaw cycles, and how long a prepared solution remains stable. Our posts on peptide storage and stability and on refrigeration and shipping cover this in detail.

How to read a Kisspeptin-10 study

When you open a paper that mentions Kisspeptin-10, check four things first:

  1. What exactly was studied? The compound name, the sequence or identifier (YNWNSFGLRF-NH2, human KP-10), and the source of the material — and whether the paper means KP-10, Kisspeptin-54, or the rodent form.
  2. In what model? In vitro assay, or another setting — and what that model can and cannot show.
  3. At what scale? The number of samples, the controls used, and whether the result was reproduced.
  4. Who funded it, and where was it published? Peer review and disclosure are part of the evidence, not decoration.

For the general background, start with What Are Peptides?

Related research on this blog

  • Sermorelin Research — a peptide studied in the GHRH literature, a different receptor family: sermorelin-research
  • What Are Peptides? — the general background for every post in this series: what-are-peptides

Glossary

  • Decapeptide: a peptide of ten amino acid residues.
  • KISS1R / GPR54: the receptor named in the Kisspeptin-10 literature; GPR54 is the former name.
  • Metastin (45–54): the catalogue name for the same ten residues, numbered inside the longer metastin peptide.
  • C-terminal amide: a chain ending in -NH2 rather than a free carboxylic acid.
  • SPPS: solid-phase peptide synthesis, the standard laboratory method for building peptides.
  • HPLC: high-performance liquid chromatography, used to measure purity.
  • Mass spectrometry (MS): used to confirm molecular weight and identity.
  • COA: Certificate of Analysis, the batch document reporting analytical results.
  • In vitro: experiments outside a living organism, e.g. in cell culture.

Frequently asked questions (research framing)

Is Kisspeptin-10 the same as Kisspeptin-54?
No. Kisspeptin-10 is a decapeptide of approximately 1302.4 Da; Kisspeptin-54 is a 54-residue peptide that ends with the same ten residues.

How is the human form different from the rodent form?
The human form ends in phenylalanine (…Arg-Phe-NH2, approximately 1302.4 Da); the rodent form ends in tyrosine (…Arg-Tyr-NH2, approximately 1318.4 Da).

What does a COA tell me?
It reports the analytical results — identity and purity — for one specific batch, measured by the laboratory that tested it. For Kisspeptin-10, the key identity checks are the ten-residue human sequence, the C-terminal amide, and the molecular weight of approximately 1302.4 Da.

Where can I learn more?
Start with the posts linked above, and read the primary literature they cite.


Research only. AVM Labs USA products are for laboratory research use only.

Scroll to Top
header ´para el telefono

Welcome back to AVM Labs USA. Sign in below to access your account and continue shopping.

Don’t have an account yet?
Create your AVM Labs USA account before signing in.